Evidence map›Paper›PMID 39006537›Full record

ReviewRheumatology advances in practice2024

The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope.

Louise Mercer, Abhishek Abhishek, Akhila Kavirayani, Alison Ahmed, Alan Davidson, Amy Foulkes, Claire Jones, Clare Nash, Emily Rose-Parfitt, Emmandeep Dhillon and 28 more

Abstract readReview
In one paragraph

Review in Rheumatology advances in practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Louise MercerDepartment of Rheumatology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK.ORCID https://orcid.org/0009-0007-2108-3393
Abhishek AbhishekAcademic Rheumatology, City Hospital Nottingham, University of Nottingham, Nottingham, UK.ORCID https://orcid.org/0000-0003-0121-4919
Akhila KavirayaniPaediatric Rheumatology, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Alison AhmedDepartment of Rheumatology, Tameside and Glossop Integrated Care NHS Foundation Trust, Ashton-Under-Lyme, UK.
Alan DavidsonCommunity Rheumatology, Modality LLP, Birmingham, UK.
Amy FoulkesDepartment of Dermatopharmacology, Salford Royal NHS Foundation Trust, Salford, UK.
Claire JonesMedicines Management, Powys Teaching Health Board, Brecon, Powys, UK.
Clare NashPharmacy Department, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
Emily Rose-ParfittDepartment of Rheumatology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
Emmandeep DhillonDepartment of Rheumatology, New Cross Hospital, Royal Wolverhampton NHS Trust, Wolverhampton, UK.
Genevieve ZabateRheumatic Diseases Unit, Western General Hospital NHS Lothian, Edinburgh, UK.
Helen TwohigSchool of Medicine, Keele University, Keele, UK.ORCID https://orcid.org/0000-0001-8781-1268
Hope De VereDepartment of Rheumatology, Gloucestershire Hospitals NHS Foundation Trust, UK.
Jennifer ScottDepartment of Hepatology and Gastroenterology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK.
John ReynoldsInstitute of Inflammation and Ageing, University of Birmingham Research Labs, Queen Elizabeth Hospital, University of Birmingham, Birmingham, UK.ORCID https://orcid.org/0000-0002-8962-4404
Julia HolmesExpert by Experience, Versus Arthritis Fellowship Expert Committee Member.
Karen HartleyDepartment of Pharmacy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
Kishore WarrierPaediatric and Adolescent Rheumatology, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Kataryzna NowakDepartment of Rheumatology, Belfast Health and Social Care Trust, Belfast, UK.ORCID https://orcid.org/0000-0002-9957-0446
Kate ParsonsExpert by Experience, UK.
Katie BechmanCentre for Rheumatic Diseases, King's College London, London, UK.
Lisa BrayDepartment of Paediatrics, St Richard's Hospital, Chichester, UK.
Madura AdikariDepartment of Rheumatology, Rotherham General Hospital, Rotherham NHS Foundation Trust, Rotherham, UK.
Natasha WoodBrannam Medical Centre, Barnstaple, UK.
Nicola FaithfullChildhood Arthritis and Rheumatic Diseases Unit, Birmingham Children's Hospital, Birmingham, UK.
Nicola GullickDepartment of Rheumatology, University Hospitals Coventry & Warwickshire, Coventry, UK.ORCID https://orcid.org/0000-0001-8970-4116
Pratyasha SahaDepartment of Rheumatology, Norfolk and Norwich University Hospital, Norfolk, UK.ORCID https://orcid.org/0000-0003-4212-5875
Rebecca HeatonDepartment of Rheumatology, Stockport NHS Foundation Trust, Stockport, UK.
Samundeeswari DeepakPaediatric & Adolescent Rheumatology, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Samantha HiderSchool of Medicine, Keele University, Keele, UK.ORCID https://orcid.org/0000-0002-9958-3909
Sameena KhalidRheumatology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals, Sheffield, UK.
Sanaa Suleiman SaidDepartment of Internal Medicine, State University of Zanzibar, Tunguu, Zanzibar, Tanzania.
Sarah RyanDepartment of Rheumatology, Midlands Partnership University NHS Foundation Trust, Stoke-on-Trent, UK.ORCID https://orcid.org/0000-0002-2202-6266
Stuart KyleDepartment of Rheumatology, North Devon District Hospital, Royal Devon University, Devon, UK.
Subhra RaghuvanshiDepartment of Rheumatology, Wrexham Maelor Hospital, Betsi Cadawaladr University Hospital, Wrexham, UK.
Su-Yin TanDepartment of Rheumatology, NHS Tayside, Dundee, UK.
Vinay ShivamurthyDepartment of Rheumatology, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
James GallowayCentre for Rheumatic Diseases, King's College London, London, UK.ORCID https://orcid.org/0000-0002-1230-2781

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This guideline will provide up-to-date, evidence-based recommendations on the safe use of non-biologic DMARDs, also called conventional synthetic DMARDs (csDMARD), across the full spectrum of autoimmune rheumatic diseases. The guideline will update the guideline published in 2017 and will be expanded to include people of all ages. Updated information on the monitoring of DMARDs and vaccinations will be included. The guideline will be developed using the methods and processes described in the British Society for Rheumatology's 'Creating clinical guidelines: our protocol', updated 2023.

Indexed as

DMARD management guideline

Identifiers

PMID39006537
PMCPMC11239329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.